John Greenland
University of California, San Francisco
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name John Greenland as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 08:34 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT07538336 · Targeting Interferon Gamma With Emapalumab to Lung Transplant Recipients With Interferon Gamma-high Acute Lung Allograft DysfunctionUniversity of California, San Francisco · not yet recruiting · Lung Transplant · principal investigator
- N/ANCT03933878 · Rapid Detection of Airway Pathogens for Lung TransplantationUniversity of California, San Francisco · completed · Lung Transplantation, Respiratory Tract Infections, Pulmonary Infection · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 08:34 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Airway epithelial cell and lymphocyte interactions in chronic lung allograft dysfunction pathogenesisR01HL161048 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · fiscal years 2022 to 2026 · $451,227 awarded in 2026Same name and institution; not confirmed by an ID
- Airway epithelial cell reprogramming mechanisms leading to chronic lung allograft dysfunctionR01HL182930 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · fiscal years 2026 · $731,287 awarded in 2026Same name and institution; not confirmed by an ID
- Cytomegalovirus Immune Responses in Chronic Lung Allograft Dysfunction PathogenesisI01CX002011 · VA · VETERANS AFFAIRS MED CTR SAN FRANCISCO · fiscal years 2020 to 2025Same name and institution; not confirmed by an ID
- Telomere Dysfunction as a cause of Chronic Lung Allograft DysfunctionR01HL151552 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · fiscal years 2020 to 2024 · $295,653 awarded in 2024Same name and institution; not confirmed by an ID
- Immune Mechanisms of Large-airway Lymphocytic BronchitisIK2CX001034 · VA · VETERANS AFFAIRS MED CTR SAN FRANCISCO · fiscal years 2015 to 2019Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 08:34 UTC. The ranking covers the 200 most relevant of 4 PubMed records, and a shared surname and initials can bring in a namesake. All 4 on PubMed
- Selective decrease of donor-reactive Tregs after liver transplantation limits Treg therapy for promoting allograft tolerance in humans.Sci Transl Med · 202284 citationsRCR 5.7
- Phase II study of accelerated hypofractionated three-dimensional conformal radiotherapy for stage T1-3 N0 M0 non-small cell lung cancer: NCIC CTG BR.25.J Natl Cancer Inst · 201463 citationsRCR 2.1
- Azathioprine for the treatment of early Parkinson's disease (AZA-PD): a randomised, double-blind, placebo-controlled, proof-of-concept, phase 2 trial.Lancet Neurol · 20267 citationsRCR 3.5
- The effect of nicardipine, a calcium channel blocker, on the sweat test in adult patients with cystic fibrosis.Respir Med · 19890 citationsRCR 0.0